Terbutaline

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C12H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N8ONU3L3PG, chemically known as 1,3-benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9ci) but generally known as terbutaline, which bears US NIH Compound Identifier 5403. European Medicines Agency schedules Terbutaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10915MIG. The term TERBUTALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules terbutaline in its Anatomical Therapeutic Chemical (ATC) Classification. TERBUTALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terbutaline under HS 29225000 and SITC 51467. As of Q4 2014, TERBUTALINE remains the US FDA Preferred Term for this commodity. Terbutaline bears US NLM identifiers UMLS ID C0039542 and NCI Concept Code C61965. SMILES: CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.